whether it's okay to use the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" indications

April 2013

You'll get questions about whether it's okay to use the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" indications.

All are approved to prevent stroke in atrial fib.

Xarelto (rivaroxaban) is also approved to prevent clots after hip or knee surgery...or to treat venous thromboembolism.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote